Free Trial

IMAC Q1 2023 Earnings Report

IMAC logo
$1.21 +0.09 (+8.04%)
(As of 12/20/2024 05:40 PM ET)

IMAC EPS Results

Actual EPS
-$3.30
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

IMAC Revenue Results

Actual Revenue
$2.09 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

IMAC Announcement Details

Quarter
Q1 2023
Time
N/A

Conference Call Resources

Why Buffett, Griffin and 100 members of Congress are Piling into this One Investment (Ad)

This isn't just another investment. It might be the last retirement stock you'll ever need. But this window of opportunity is closing fast.

Click here for the ticker >>>

IMAC Earnings Headlines

Could This Tiny Device Help You Make an Extra $30k a Year?
I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more than $9 trillion. That’s nearly 10 times more money than the market caps of Tesla… SpaceX… PayPal… Neuralink… and X… COMBINED.
See More IMAC Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like IMAC? Sign up for Earnings360's daily newsletter to receive timely earnings updates on IMAC and other key companies, straight to your email.

About IMAC

IMAC (NASDAQ:BACK) owns and manages innovative medical advancements and care regeneration centers, and backspace clinics in the United States. The company's outpatient medical clinics provide regenerative, orthopedic, and minimally invasive procedures and therapies to patients with sports injuries, ligament and tendon damage, and other related soft tissue conditions, as well as back, knee, and joint pains. It also provides medical treatments, regenerative, spinal decompression, chiropractic manipulation, and physical medicine and therapy. IMAC Holdings, Inc. was founded in 2000 and is headquartered in Franklin, Tennessee.

View IMAC Profile

More Earnings Resources from MarketBeat

Upcoming Earnings